Free Trial

Teva Pharmaceutical Industries (TEVA) Competitors

$16.84
+0.02 (+0.12%)
(As of 06/10/2024 ET)

TEVA vs. TAK, ALNY, GMAB, RPRX, BGNE, BMRN, VTRS, UTHR, RDY, and SRPT

Should you be buying Teva Pharmaceutical Industries stock or one of its competitors? The main competitors of Teva Pharmaceutical Industries include Takeda Pharmaceutical (TAK), Alnylam Pharmaceuticals (ALNY), Genmab A/S (GMAB), Royalty Pharma (RPRX), BeiGene (BGNE), BioMarin Pharmaceutical (BMRN), Viatris (VTRS), United Therapeutics (UTHR), Dr. Reddy's Laboratories (RDY), and Sarepta Therapeutics (SRPT). These companies are all part of the "pharmaceutical preparations" industry.

Teva Pharmaceutical Industries vs.

Teva Pharmaceutical Industries (NYSE:TEVA) and Takeda Pharmaceutical (NYSE:TAK) are both large-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, community ranking, risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation.

Takeda Pharmaceutical has higher revenue and earnings than Teva Pharmaceutical Industries. Teva Pharmaceutical Industries is trading at a lower price-to-earnings ratio than Takeda Pharmaceutical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Teva Pharmaceutical Industries$15.85B1.19-$559M-$0.41-41.09
Takeda Pharmaceutical$28.20B1.52$994.06M$0.5524.56

Takeda Pharmaceutical has a net margin of 6.18% compared to Teva Pharmaceutical Industries' net margin of -2.88%. Teva Pharmaceutical Industries' return on equity of 37.33% beat Takeda Pharmaceutical's return on equity.

Company Net Margins Return on Equity Return on Assets
Teva Pharmaceutical Industries-2.88% 37.33% 6.73%
Takeda Pharmaceutical 6.18%9.92%4.71%

Teva Pharmaceutical Industries received 1214 more outperform votes than Takeda Pharmaceutical when rated by MarketBeat users. Likewise, 67.63% of users gave Teva Pharmaceutical Industries an outperform vote while only 56.82% of users gave Takeda Pharmaceutical an outperform vote.

CompanyUnderperformOutperform
Teva Pharmaceutical IndustriesOutperform Votes
1314
67.63%
Underperform Votes
629
32.37%
Takeda PharmaceuticalOutperform Votes
100
56.82%
Underperform Votes
76
43.18%

In the previous week, Teva Pharmaceutical Industries had 7 more articles in the media than Takeda Pharmaceutical. MarketBeat recorded 10 mentions for Teva Pharmaceutical Industries and 3 mentions for Takeda Pharmaceutical. Teva Pharmaceutical Industries' average media sentiment score of 0.79 beat Takeda Pharmaceutical's score of 0.73 indicating that Teva Pharmaceutical Industries is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Teva Pharmaceutical Industries
4 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Takeda Pharmaceutical
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Teva Pharmaceutical Industries currently has a consensus target price of $15.88, suggesting a potential downside of 5.76%. Takeda Pharmaceutical has a consensus target price of $14.00, suggesting a potential upside of 3.63%. Given Takeda Pharmaceutical's higher probable upside, analysts clearly believe Takeda Pharmaceutical is more favorable than Teva Pharmaceutical Industries.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Teva Pharmaceutical Industries
0 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.75
Takeda Pharmaceutical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

54.1% of Teva Pharmaceutical Industries shares are held by institutional investors. Comparatively, 9.2% of Takeda Pharmaceutical shares are held by institutional investors. 0.6% of Teva Pharmaceutical Industries shares are held by company insiders. Comparatively, 0.0% of Takeda Pharmaceutical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Teva Pharmaceutical Industries has a beta of 0.91, suggesting that its share price is 9% less volatile than the S&P 500. Comparatively, Takeda Pharmaceutical has a beta of 0.55, suggesting that its share price is 45% less volatile than the S&P 500.

Summary

Teva Pharmaceutical Industries beats Takeda Pharmaceutical on 10 of the 17 factors compared between the two stocks.

Get Teva Pharmaceutical Industries News Delivered to You Automatically

Sign up to receive the latest news and ratings for TEVA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TEVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TEVA vs. The Competition

MetricTeva Pharmaceutical IndustriesPharmaceutical IndustryMedical SectorNYSE Exchange
Market Cap$18.88B$6.91B$5.12B$17.78B
Dividend YieldN/A2.65%5.24%3.57%
P/E Ratio-41.0921.65163.0025.05
Price / Sales1.19412.582,463.1115.35
Price / Cash4.7819.9531.9315.70
Price / Book2.325.734.985.01
Net Income-$559M$145.74M$109.09M$975.80M
7 Day Performance1.17%-1.62%-0.77%-0.37%
1 Month Performance3.66%-0.10%-0.01%-1.18%
1 Year Performance129.81%-5.78%3.67%9.74%

Teva Pharmaceutical Industries Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TAK
Takeda Pharmaceutical
0.8666 of 5 stars
$13.47
+0.5%
$14.00
+3.9%
-16.7%$42.63B$28.20B24.4949,095
ALNY
Alnylam Pharmaceuticals
4.7162 of 5 stars
$149.73
0.0%
$216.19
+44.4%
-19.6%$18.94B$1.83B-55.872,100Positive News
GMAB
Genmab A/S
2.8863 of 5 stars
$28.64
+0.5%
$49.25
+72.0%
-27.5%$18.94B$2.39B23.872,204Gap Down
RPRX
Royalty Pharma
4.8648 of 5 stars
$27.01
0.0%
$43.00
+59.2%
-16.8%$16.14B$2.36B20.1651
BGNE
BeiGene
2.6925 of 5 stars
$158.26
+2.0%
$251.93
+59.2%
-27.8%$15.14B$2.46B-20.9110,600Positive News
BMRN
BioMarin Pharmaceutical
4.9615 of 5 stars
$78.37
-0.9%
$106.11
+35.4%
-9.2%$14.88B$2.42B73.243,401Positive News
Gap Up
VTRS
Viatris
0.4092 of 5 stars
$10.52
-0.1%
$11.00
+4.6%
+12.0%$12.53B$15.43B-175.3338,000
UTHR
United Therapeutics
4.2676 of 5 stars
$276.04
+1.0%
$309.44
+12.1%
+20.5%$12.25B$2.33B13.051,168
RDY
Dr. Reddy's Laboratories
0.6814 of 5 stars
$69.60
+1.2%
$81.00
+16.4%
+26.8%$11.61B$279.16B17.2725,863Gap Up
SRPT
Sarepta Therapeutics
4.7063 of 5 stars
$118.12
-1.3%
$164.00
+38.8%
-4.0%$11.16B$1.24B1,073.821,314

Related Companies and Tools

This page (NYSE:TEVA) was last updated on 6/11/2024 by MarketBeat.com Staff

From Our Partners